FDA Roundup: Nasal Spray for Gastroparesis in Women
June 8th 2018This week, the FDA received an application for a metoclopramide nasal spray and a receptor agonist for hypoactive sexual desire disorder, approved baricitinib on its second try, and granted Priority Review to emicizumab for hemophilia A.
FDA Roundup: The First Prosthetic Iris
June 1st 2018This week, the FDA approved the first standalone prosthetic iris, granted priority review to a pediatric anti-epileptic and a postpartum depression drug, accepted another try from an opioid use disorder drug, and announced new plans against the opioid epidemic.
MDNN: Cinnamon-Flavored E-Cigarettes, Hypertension Prevalence, Right-to-Try Law
May 25th 2018This week on MDNN: Cinnamon flavoring in e-cigarettes has been found to disrupt the lungs’ anti-bacterial defense system, new hypertension guidelines have increased the condition's prevalence, and the US Congress passed a right-to-try bill.
MDNN: Physician Stigmatizing, Pokemon GO, Depression by Gender, and Fast Food Fertility
May 11th 2018This week on MDNN: Stigmatizing phrasing influences patient care, Pokemon GO improves behavioral health, depressed women and men differentiate in gene expression, and fast food can stall a woman's time to pregnancy.
MDNN: Opioid Overprescription, Medical Marijuana's Effects, Grindr Scandal
April 6th 2018This week on MDNN: Physician report being unaware of how many opioids they prescribe, legalized marijuana cuts down on opioid rates in Medicaid patients, Grindr responds to leak they share users' HIV statuses, and the FDA recalls salmonella-containing kratom.